GlassScriptPhysician profile
Jonathan Ramalho
NPI 1821452780
$28,000.62
in general payments reported to CMS, 2019-2025
19 companies · $8,096 in 2025
The $8,096 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $79.30 · 2021: $2,702 · 2022: $11K · 2023: $4,509 · 2024: $1,752 · 2025: $8,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,477 · Food and Beverage: $5,087 · Education: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,476.73 |
| Food and Beverage | $5,087.47 |
| Education | $792.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $15,458.58 | 2021-2025 | Acticor 7 Vr-T Dx, Rivacor 7 Dr-T, Edora 8 Dr-T |
| Medtronic, INC. | $7,306.17 | 2021-2025 | Micra, Selectsecure, Azure Xt Dr Mri Surescan |
| Baylis Medical Company INC | $1,883.70 | 2021 | |
| Medical Device Business Services, INC. | $1,370.20 | 2024 | Carto 3 |
| Boston Scientific Corporation | $618.47 | 2022-2025 | Rhythmia Mapping System, Resonate El Icd Vr, Watchman |
| Abbott Laboratories | $309.00 | 2025 | Amplatzer, Aveir, Perclose Prostyle |
| Amgen INC. | $250.51 | 2020-2021 | |
| Biosense Webster, INC. | $241.16 | 2024-2025 | Carto 3 |
| Kestra Medical Technology Services, INC. | $127.32 | 2025 | Assure Wcd |
| Atricure, INC. | $103.03 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Novartis Pharmaceuticals Corporation | $80.96 | 2024 | |
| Sanofi-Aventis U.S. LLC | $50.00 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $43.93 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.79 | 2025 | Lifevest |
| Merck Sharp & Dohme LLC | $35.80 | 2022-2024 | Verquvo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $23.61 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.72 | 2025 | Jardiance |
| Davol INC. | $18.26 | 2020 | |
| Astellas Pharma US INC | $17.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Ramalho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.